The incidence of bladder tumors has increased in the last years. Often, at the time of diagnosis the tumor has reached a stage in which a curative radical therapy is no longer possible. With the help of urinary cytology it is often possible to obtain evidence of tumors at an early stage, before clinical symptoms become evident. For this reason, urinary cytology would appear to be a reasonable screening method for tumor detection. In the framework laws concerning measures for the preventive treatment of tumors, there is no provision for the early detection of tumors of the bladder and urinary tract. As urine is easily obtainable it appears that urinary cytology could easily be integrated into such a program for early detection of tumors. The evaluation is relatively costly in man-hours and, therefore, not suitable for screening. For this reason, urothelical cells were investigated in respect to their use as a diagnostic parameter in an automated screening test. Urinary cells can be analyzed automatically, but little experience has been made in this area of research. However, it seems that automation of urinary cytology would be a step towards screening method for tumors of the bladder and urinary tract.

Keywords:
Urinary cytology, Automated prescreening, Microscopic cytophotometry
This content is only available via PDF.
© 1980 S. Karger AG, Basel
1980
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.